| Product containing precisely abacavir (as abacavir sulfate) 600 milligram and dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) | | Abacavir (as abacavir sulfate) 600 mg and dolutegravir (as dolutegravir sodium) 50 mg and lamivudine 300 mg oral tablet |
| | Id | 1079891000202103 | | Status | Defined |
| Has BoSS | Lamivudine | | Has precise active ingredient | Lamivudine | | Has presentation strength denominator unit | Tablet | | Has presentation strength numerator unit | mg |
|